Latest filing published 08 Sept 2026 for Recursion Pharmaceuticals, INC., €68k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Najat Khan: trading record in brief
All filings by Najat Khan on record concern Recursion Pharmaceuticals, Inc. The record holds 2 filings, for trades running from 5 June 2026 to 8 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 8 September 2026 came the latest disclosure, a transaction for €68k in Recursion Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Najat Khan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,408 shares@ US$3.5176CommonSEC144:0001628280-26-060859
- 23,588 shares@ US$3.58060.0044% mcap100.0% of flowCommonSEC144:0001628280-26-041114
2 of 2 declarations
